Osaic Holdings
RGC icon

Osaic Holdings’s Regencell Bioscience RGC Stock Holding History

Osaic Holdings’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91K Buy
642
+415
+183% +$10K ﹤0.01% 7044
2026
Q1 		$5.77K Hold
227
– – ﹤0.01% 6612
2025
Q4 		$4.77K Hold
227
– – ﹤0.01% 6729
2025
Q3 		$3.28K Buy
227
+37
+19% +$531 ﹤0.01% 6961
2025
Q2 		$3.24K Buy
+190
New +$2.32K ﹤0.01% 6767

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Quadrature Capital
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Osaic Holdings's RGC Position: Q2 2026 in Review

Osaic Holdings increased its Regencell Bioscience (RGC) stake by 183% in Q2 2026, buying an estimated $10K and bringing the position to 642 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #7044.

Osaic Holdings first reported a position in RGC in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.77K in Q1 2026. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Osaic Holdings held 642 shares of Regencell Bioscience worth $3.91K as of Q2 2026.
  • Osaic Holdings bought 415 Regencell Bioscience shares in Q2 2026, an estimated $10K.
  • Regencell Bioscience made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7044 holding.
  • Osaic Holdings first reported a position in Regencell Bioscience in Q2 2025 and has held it in 5 quarters since.
  • Osaic Holdings's Regencell Bioscience position peaked at $5.77K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.